D J Oblon

769 total citations
8 papers, 634 citations indexed

About

D J Oblon is a scholar working on Pathology and Forensic Medicine, Surgery and Molecular Biology. According to data from OpenAlex, D J Oblon has authored 8 papers receiving a total of 634 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pathology and Forensic Medicine, 2 papers in Surgery and 2 papers in Molecular Biology. Recurrent topics in D J Oblon's work include Hematopoietic Stem Cell Transplantation (2 papers), Chemotherapy-induced organ toxicity mitigation (2 papers) and Cancer therapeutics and mechanisms (1 paper). D J Oblon is often cited by papers focused on Hematopoietic Stem Cell Transplantation (2 papers), Chemotherapy-induced organ toxicity mitigation (2 papers) and Cancer therapeutics and mechanisms (1 paper). D J Oblon collaborates with scholars based in United States. D J Oblon's co-authors include Roy S. Weiner, Lori Anderson, Charles A. Dinarello, James R. Zucali, M.A. Gross, Kelly Pendergrass, Graydon Harker, John D. Hainsworth, W. Henwood Harvey and Basil Kasimis and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

D J Oblon

8 papers receiving 607 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
D J Oblon United States	7	195	170	138	109	80	8	634
Sidney Trubowitz United States	14	183 0.9×	81 0.5×	87 0.6×	104 1.0×	124 1.6×	32	766
Ramsès Wassef Canada	14	132 0.7×	115 0.7×	228 1.7×	26 0.2×	74 0.9×	31	610
M. Ruud Halie Netherlands	13	116 0.6×	85 0.5×	52 0.4×	88 0.8×	115 1.4×	18	448
W. M. Gallmeier Germany	14	167 0.9×	152 0.9×	147 1.1×	110 1.0×	74 0.9×	52	676
Takashi Sakano Japan	16	108 0.6×	42 0.2×	176 1.3×	43 0.4×	198 2.5×	72	740
Ikuo Imazeki Japan	11	228 1.2×	174 1.0×	59 0.4×	126 1.2×	215 2.7×	18	799
Yuji Sudo Japan	15	190 1.0×	78 0.5×	139 1.0×	46 0.4×	158 2.0×	34	683
Stefania Gaspari Italy	15	180 0.9×	96 0.6×	67 0.5×	241 2.2×	218 2.7×	46	659
Yuji Nishio Japan	14	170 0.9×	87 0.5×	191 1.4×	33 0.3×	71 0.9×	38	528
Conleth Feighery Ireland	16	297 1.5×	77 0.5×	144 1.0×	147 1.3×	130 1.6×	24	995

Countries citing papers authored by D J Oblon

Since Specialization

Citations

This map shows the geographic impact of D J Oblon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D J Oblon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D J Oblon more than expected).

Fields of papers citing papers by D J Oblon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D J Oblon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D J Oblon. The network helps show where D J Oblon may publish in the future.

Co-authorship network of co-authors of D J Oblon

This figure shows the co-authorship network connecting the top 25 collaborators of D J Oblon. A scholar is included among the top collaborators of D J Oblon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D J Oblon. D J Oblon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Sweeney, Joseph D., et al.. (2000). A comparison of prestorage WBC‐reduced whole‐blood‐derived platelets and bedside‐filtered whole‐blood‐derived platelets in autologous progenitor cell transplant. Transfusion. 40(7). 794–800. 15 indexed citations

Oblon, D J, S. Paul, & Ronald A. Yankee. (1997). Allogeneic transplantation after a conditioning regimen with ifosfamide, carboplatin and etoposide (ICE). Bone Marrow Transplantation. 20(5). 421–423. 4 indexed citations

Oblon, D J, et al.. (1997). Propantheline protects the oral mucosa after high-dose ifosfamide, carboplatin, etoposide and autologous stem cell transplantation. Bone Marrow Transplantation. 20(11). 961–963. 20 indexed citations

Ramphal, Reuben, William E. Bolger, D J Oblon, et al.. (1992). Vancomycin is not an essential component of the initial empiric treatment regimen for febrile neutropenic patients receiving ceftazidime: a randomized prospective study. Antimicrobial Agents and Chemotherapy. 36(5). 1062–1067. 75 indexed citations

Hainsworth, John D., W. Henwood Harvey, Kelly Pendergrass, et al.. (1991). A single-blind comparison of intravenous ondansetron, a selective serotonin antagonist, with intravenous metoclopramide in the prevention of nausea and vomiting associated with high-dose cisplatin chemotherapy.. Journal of Clinical Oncology. 9(5). 721–728. 121 indexed citations

Wajsman, Zev, et al.. (1990). Bladder-sparing approach in the treatment of invasive bladder cancer.. PubMed. 8(3). 210–5. 12 indexed citations

Zucali, James R., Charles A. Dinarello, D J Oblon, et al.. (1986). Interleukin 1 stimulates fibroblasts to produce granulocyte-macrophage colony-stimulating activity and prostaglandin E2.. Journal of Clinical Investigation. 77(6). 1857–1863. 378 indexed citations

Oblon, D J, et al.. (1985). Etoposide, carmustine, bleomycin, and methotrexate with leucovorin rescue as re-treatment for unfavorable non-Hodgkin's lymphoma.. PubMed. 69(7-8). 783–6. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact